<DOC>
	<DOCNO>NCT00169611</DOCNO>
	<brief_summary>Neurofibromatosis type 1 ( NF1 ) autosomal dominant disorder estimate prevalence 1/2190 1/6711 . Attention deficit hyperactivity disorder ( ADHD ) report common NF1 . We , researcher Hospices Civils de Lyon , design randomize , double blind , placebo control , crossover trial total follow-up duration 9 week evaluate effect methylphenidate ( MPH ) improvement simplify parent Conners ' Rating Scale . In parallel exploratory study compare nature attention deficit disorder NF1 child 30 ADHD NF1-free control . Children age 7 12 year eligible intelligence quotient ( IQ ) 80 120 . Fifty subject ( 25 period ) require test primary study hypothesis .</brief_summary>
	<brief_title>NF1-Attention : Study Children With Neurofibromatosis Type 1 Treated Methylphenidate</brief_title>
	<detailed_description />
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Age 712 year IQ 80120 . Gender : male female Children neurofibromatosis type 1 ( accord National Institutes Health [ NIH ] 1988 ) . Patients school difficulty point parent teacher Patients attention difficulty define anamnesis IQ &gt; 120 IQ &lt; 80 Child depression Unwillingness participate Patients cerebral complication neurofibromatosis type 1 ( chiasma glioma , moyamoya ) detect cerebral magnetic resonance imaging ( MRI ) . Participation another study</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Neurofibromatosis type 1</keyword>
	<keyword>Attention deficit hyperactivity disorder school difficulty</keyword>
	<keyword>methylphenidate</keyword>
</DOC>